CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | GOLDSTEIN DOV A MD Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2025-02-18 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +530,000 | 530,000 | ||
| 2025-02-18 | Barton Shane Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-12-18 | Barton Shane Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2024-10-03 | Pande Vijay Satyanand Director | Purchase | +25,306 | $19.90 | $504K | 1,119,195 |
| 2024-10-02 | Pande Vijay Satyanand Director | Purchase | +67,096 | $19.73 | $1.3M | 1,093,889 |
| 2024-10-01 | Pande Vijay Satyanand Director | Purchase | +126,793 | $19.73 | $2.5M | 1,026,793 |
| 2024-09-27 | Hemrajani Rekha Director | Purchase | +3,000 | $18.00 | $54K | 3,000 |
| 2024-09-27 | Barton Shane Principal Accounting Officer | Purchase | +2,632 | $18.00 | $47K | 2,632 |
| 2024-09-27 | Cormorant Asset Management, LP Former 10% Owner | Conversion | +1,179,529 | 1,179,529 | ||
| 2024-09-27 | Cormorant Asset Management, LP Former 10% Owner | Purchase | +450,000 | $18.00 | $8.1M | 1,629,529 |
| 2024-09-27 | Cormorant Asset Management, LP Former 10% Owner | Conversion · Series D Redeemable Convertible Preferred Stock | −5,263,772 | 0 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion | +855,972 | 855,972 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion | +413,100 | 1,269,072 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion | +189,609 | 189,609 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion | +655,294 | 655,294 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Purchase | +900,000 | $18.00 | $16.2M | 900,000 |
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion · Series A-1 Preferred Stock | −3,819,863 | 0 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion · Series B Preferred Stock | −1,843,502 | 0 | ||
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion · Series C Preferred Stock | −846,152 | 0 |
Page 5 of 7 · 124 trades